Transcutaneous Electrical Nerve Stimulation Market is Anticipated to Witness High Growth Owing to Rising Prevalence of Chronic Pain Disorders

 

Transcutaneous Electrical Nerve Stimulation Market

The transcutaneous electrical nerve stimulation (TENS) market involves devices that stimulate peripheral nerves through the skin using low-voltage electric currents for the management of different kinds of pain like acute and chronic pains. TENS devices are easy to use, portable, non-invasive, and drug-free pain relievers. They work by blocking pain signals from reaching the brain. The growing prevalence of chronic pain-causing conditions like arthritis, post-surgical syndrome, and neuropathic pain is driving the demand for pain management devices like TENS.

The global transcutaneous electrical nerve stimulation market is estimated to be valued at US$ 5.23 Bn in 2024 and is expected to exhibit a CAGR of 4.2% over the forecast period 2024 to 2031.

Key Takeaways

Owing to the growing geriatric population suffering from age-related pain conditions in regions like North America, Europe, Asia Pacific and availability of favorable reimbursement policies, these regions dominate the global Transcutaneous Electrical Nerve Stimulation Market Size currently. However, players are also focusing on developing economies like Latin America and Middle East & Africa for future growth opportunities.

The rising prevalence of chronic pain and lack of effective traditional pain management options present significant growth opportunities in the TENS market. With increasing awareness and acceptance of non-drug pain relief solutions, the demand for TENS devices is expected to grow multifold over the coming years.

Key players operating in the Transcutaneous Electrical Nerve Stimulation Market Size are Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, Omron Healthcare, Inc., Nevro Corp., DJO Global, Inc., Zynex Medical, COMPex, ITO Co., Ltd., Beurer GmbH, BTL, Chattanooga International, EMS Physio Ltd., BioMedical Life Systems, Inc., Current Solutions, LLC, Zewa, Inc., Walgreen Co., Pain Management Technologies, Inc., OPTP, and Roscoe Medical. These players are focusing on new product launches and geographical expansion to strengthen their market position.

Market Drivers

The increasing geriatric population worldwide will drive the growth of the TENS market over the forecast period. Older people are more prone to chronic pain conditions like osteoarthritis and backaches. Moreover, the rising prevalence of lifestyle diseases and road accidents resulting in nerve injuries is boosting the demand for pain management solutions.

Favorable reimbursement policies for pain treatment devices in developed regions encourage the adoption of advanced therapies like TENS. Domestic players are also able to leverage government funding and initiatives to boost R&D and commercialization of innovative TENS devices.

Market Restraints

However, the high cost of advanced TENS devices is a major restraint for their widespread adoption in developing and underdeveloped regions where people have low disposable incomes. Lack of awareness about alternative pain management options like TENS also hinders the market growth globally.

Segment Analysis
The transcutaneous electrical nerve stimulation market is dominanted by the pain management segment. This segment accounted for more than 50% of market share in 2024 as TENS devices are widely used to manage both chronic and acute pain. TENS devices provide pain relief through the inhibition of pain signal transmission in the nervous system and activation of the body's natural painkilling pathways. The sports medicine segment is the fastest growing segment and is expected to witness a CAGR of around 5% during the forecast period. This growth can be attributed to the increasing applications of TENS devices in athletic recovery and physical therapy.

Global Analysis
North America currently dominates the transcutaneous electrical nerve stimulation market and accounts for over 40% of the global market share. This can be attributed to the presence of major players and advanced healthcare infrastructure in the region. However, Asia Pacific is expected to witness the highest growth during the forecast period owing to rising healthcare expenditures, growing medical tourism, and increasing prevalence of chronic diseases. China, India and Japan are emerging as major hubs for TENS device manufacturing and are expected see a CAGR of around 6% between 2024 to 2031.

Get More Insights On Transcutaneous Electrical Nerve Stimulation Market

About Author:

 Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191)